Mohan, D.; Mvundura, M.; Sampson, S.; Adepoju, V.A.; Bakunawa, G.B.; Umebido, C.; Ekeh, A.; Little, J.; Daly, C.; Morgan, C.;
et al. Evaluating the Impact of Needle-Free Delivery of Inactivated Polio Vaccine on Nigeria’s Routine Immunization Program: An Implementation Hybrid Trial. Vaccines 2025, 13, 533.
https://doi.org/10.3390/vaccines13050533
AMA Style
Mohan D, Mvundura M, Sampson S, Adepoju VA, Bakunawa GB, Umebido C, Ekeh A, Little J, Daly C, Morgan C,
et al. Evaluating the Impact of Needle-Free Delivery of Inactivated Polio Vaccine on Nigeria’s Routine Immunization Program: An Implementation Hybrid Trial. Vaccines. 2025; 13(5):533.
https://doi.org/10.3390/vaccines13050533
Chicago/Turabian Style
Mohan, Diwakar, Mercy Mvundura, Sidney Sampson, Victor Abiola Adepoju, Garba Bello Bakunawa, Chidinma Umebido, Adachi Ekeh, Joe Little, Catherine Daly, Christopher Morgan,
and et al. 2025. "Evaluating the Impact of Needle-Free Delivery of Inactivated Polio Vaccine on Nigeria’s Routine Immunization Program: An Implementation Hybrid Trial" Vaccines 13, no. 5: 533.
https://doi.org/10.3390/vaccines13050533
APA Style
Mohan, D., Mvundura, M., Sampson, S., Adepoju, V. A., Bakunawa, G. B., Umebido, C., Ekeh, A., Little, J., Daly, C., Morgan, C., Atobatele, S., LaBarre, P., & Oliveras, E., on behalf of the Nigeria Tropis® Evaluation Team.
(2025). Evaluating the Impact of Needle-Free Delivery of Inactivated Polio Vaccine on Nigeria’s Routine Immunization Program: An Implementation Hybrid Trial. Vaccines, 13(5), 533.
https://doi.org/10.3390/vaccines13050533
